Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||
| Earning before tax | -4,959.02%-123.57M | -28.12%-21.74M | -56.32%2.54M | 20.54%-16.97M | --5.82M | -155.53%-21.36M | --38.47M |
| Profit adjustment | |||||||
| Interest (income) - adjustment | -25.75%-884K | -67.76%-1.48M | -129.74%-703K | -25.86%-881K | ---306K | -81.35%-700K | ---386K |
| Investment loss (gain) | 29.65%-529K | 5.01%-1.57M | -9.46%-752K | 18.97%-1.66M | ---687K | -79.23%-2.05M | ---1.14M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | --300K | ---- |
| Impairment and provisions: | -957.83%-712K | 389.40%4.37M | --83K | -106.37%-1.51M | ---- | 84,571.43%23.71M | --28K |
| -Other impairments and provisions | -957.83%-712K | 389.40%4.37M | --83K | -106.37%-1.51M | ---- | 84,571.43%23.71M | --28K |
| Revaluation surplus: | 1,519.03%122.76M | -25.24%41.09M | -61.37%7.58M | 70.14%54.96M | --19.63M | 234.98%32.3M | --9.64M |
| -Other fair value changes | 1,519.03%122.76M | -25.24%41.09M | -61.37%7.58M | 70.14%54.96M | --19.63M | 234.98%32.3M | --9.64M |
| Asset sale loss (gain): | --563K | ---- | ---- | ---- | ---- | 153.19%119K | --47K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 153.19%119K | --47K |
| -Loss (gain) from selling other assets | --563K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -9.30%1.43M | -6.23%2.76M | 9.41%1.58M | 1.77%2.94M | --1.45M | -28.30%2.89M | --4.03M |
| -Depreciation | -10.65%235K | 22.01%521K | 50.29%263K | 62.36%427K | --175K | -64.70%263K | --745K |
| -Amortization of intangible assets | 84.62%48K | -16.00%63K | -56.67%26K | 74.42%75K | --60K | 230.77%43K | --13K |
| Financial expense | -30.92%478K | -28.92%1.35M | -30.38%692K | -9.63%1.9M | --994K | 45.02%2.1M | --1.45M |
| Special items | 109.64%13.56M | 3,663.83%18.1M | 2,595.83%6.47M | 395.88%481K | --240K | 592.86%97K | --14K |
| Operating profit before the change of operating capital | -25.10%13.1M | 9.22%42.87M | -35.53%17.5M | 4.94%39.25M | --27.14M | -28.27%37.4M | --52.15M |
| Change of operating capital | |||||||
| Accounts receivable (increase)decrease | -133.73%-4.29M | 201.41%11.18M | 238.77%12.73M | -173.85%-11.03M | ---9.18M | 75.29%-4.03M | ---16.29M |
| Accounts payable increase (decrease) | 44.03%-7.39M | -31.34%8.69M | -304.69%-13.2M | 222.26%12.66M | ---3.26M | -180.84%-10.36M | --12.81M |
| prepayments (increase)decrease | 45.40%-819K | -856.90%-5.13M | 23.35%-1.5M | 91.29%-536K | ---1.96M | -76.25%-6.15M | ---3.49M |
| Special items for working capital changes | 113.32%49K | -1,256.52%-1.6M | 35.66%-368K | 103.79%138K | ---572K | -258.81%-3.64M | --2.29M |
| Cash from business operations | -95.70%652K | 38.37%56.02M | 24.55%15.16M | 206.03%40.49M | --12.17M | -72.13%13.23M | --47.46M |
| Interest received - operating | -65.53%222K | -38.51%463K | 127.56%644K | 83.21%753K | --283K | 50.55%411K | --273K |
| Interest paid - operating | -11.76%-57K | 66.28%-58K | 48.48%-51K | 27.12%-172K | ---99K | -151.06%-236K | ---94K |
| Net cash from operations | -94.81%817K | 37.40%56.42M | 27.49%15.75M | 206.37%41.07M | --12.36M | -71.87%13.4M | --47.64M |
| Cash flow from investment activities | |||||||
| Interest received - investment | 3,845.45%434K | 1,389.83%879K | --11K | --59K | ---- | ---- | ---- |
| Loan receivable (increase) decrease | -26.50%1.03M | 147.71%1.67M | 115.05%1.4M | 66.61%-3.5M | ---9.3M | -23.35%-10.48M | ---8.5M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---30M | ---- | ---- | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | --6K |
| Purchase of fixed assets | ---- | 99.31%-7K | 56.25%-7K | 19.67%-1.02M | ---16K | -618.08%-1.27M | ---177K |
| Purchase of intangible assets | ---- | -184.85%-282K | ---- | -59.68%-99K | ---- | 0.00%-62K | ---62K |
| Recovery of cash from investments | -23.54%130.61M | -41.69%331.37M | -29.49%170.81M | 3.94%568.31M | --242.26M | 43.32%546.79M | --381.51M |
| Cash on investment | 24.76%-148.98M | 36.57%-351.02M | 18.53%-198M | -3.91%-553.35M | ---243.05M | -22.42%-532.54M | ---435M |
| Net cash from investment operations | 34.42%-16.91M | 11.32%-17.38M | -155.20%-25.79M | -905.01%-19.6M | ---10.1M | 103.91%2.44M | ---62.22M |
| Net cash before financing | -60.40%-16.09M | 81.89%39.04M | -545.71%-10.03M | 35.51%21.46M | --2.25M | 208.63%15.84M | ---14.58M |
| Cash flow from financing activities | |||||||
| New borrowing | --10M | -62.09%30M | ---- | 193.08%79.13M | --39.13M | -24.97%27M | --35.99M |
| Refund | ---- | 42.88%-40M | ---- | -112.31%-70.03M | ---31.44M | -137.30%-32.99M | ---13.9M |
| Issuing shares | 1,097.95%221.84M | 15,331.67%18.52M | --18.52M | --120K | ---- | ---- | ---- |
| Interest paid - financing | 37.44%-421K | 67.38%-1.34M | 80.15%-673K | -245.75%-4.11M | ---3.39M | -68.41%-1.19M | ---706K |
| Absorb investment income | ---- | -135.00%-35K | ---- | --100K | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | -59.50%-22.21M | -1,112.18%-26.78M | ---13.92M | ---2.21M | ---- | ---- | ---- |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | --2M |
| Other items of the financing business | ---- | -13.33%-17M | ---17M | ---15M | ---- | ---- | --22K |
| Net cash from financing operations | 1,543.21%207.66M | -167.98%-38.81M | -573.48%-14.39M | -61.49%-14.48M | --3.04M | -143.10%-8.97M | --20.81M |
| Effect of rate | -47,100.00%-1.41M | 221.47%569K | -99.47%3K | -44.51%177K | --564K | 489.02%319K | ---82K |
| Net Cash | 884.42%191.57M | -96.76%226K | -561.66%-24.42M | 1.60%6.98M | --5.29M | 10.31%6.87M | --6.23M |
| Begining period cash | 1.43%56.31M | 14.80%55.51M | 14.80%55.51M | 17.46%48.35M | --48.35M | 17.55%41.17M | --35.02M |
| Cash at the end | 692.70%246.47M | 1.43%56.31M | -42.64%31.09M | 14.80%55.51M | --54.21M | 17.46%48.35M | --41.17M |
| Cash balance analysis | |||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | --43.49M | ---- | --22.1M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | --43.49M | ---- | --22.1M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.